- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Familial Cancer and Germline Genetics
This special issue belongs to the section “Cancer Biomarkers“.
Special Issue Information
Dear Colleague,
Both original articles and reviews are welcome. The focus of this Special Issue is two-fold. It will cover novel family studies on diverse cancers—novelty would be demonstrated through new types of familial clustering, high risk levels and statistical power, and possibly through populations not commonly reported. The technical requirements are diagnostic accuracy and unbiased selection of patients and family members. Results on germline genetics should be linked to families with either population, experimental, or in silico evidence on pathogenicity. Alternatively, large sequencing studies on defined sporadic cancers could be acceptable, particularly if justified through unique aspects such as rare cancers, whole-genome coverage, new populations, etc. Standard panel sequencing results are of lower priority.
The guest editors will be happy to consider inquiries about article suitability (please address them to k.hemminki@dkfz.de).
Prof. Kari Hemminki
Dr. Asta Försti
Prof. Richard Houlston
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- familial clustering
- risk between different cancers
- multiplex families
- whole-genome sequencing
- Mendelian cancers
- high-risk variant
- pathogenic variant
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

